Tech Company Financing Transactions
Experic Funding Round
Experic closed a Series B investment round on 10/5/2023. Backers included private investors.
Transaction Overview
Company Name
Announced On
10/5/2023
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to bolster its presence in the biopharmaceutical industry by expanding its service offerings and making strategic investments in its previously announced analytical laboratory and spray drying capabilities.
Company Information
Company Status
Private & Independent
Industry
AdTech
Mailing Address
2 Clarke Drive
Cranbury, NJ 08512
USA
Cranbury, NJ 08512
USA
Phone
Website
Email Address
Overview
Experic, a contract development and manufacturing organization (CDMO) and pharmaceutical supply services company, supports every phase of a product's life cycle from conception to clinical and commercial scale, across a range of dosing and packaging formats, including tablets, capsules, and low dose dry powder inhalation. From our state-of-the-art, Class A cGMP facility, we manage global delivery of the highest quality products, even for expedited projects, while providing unparalleled knowledge, expertise, and customer service.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Wood
Chief Scientific Officer
Justin Lacombe
VP - Operations
Brian Fagan
Browse more venture capital transactions:
Prev: 10/5/2023: Inovedis venture capital transaction
Next: 10/5/2023: SuperOrdinary venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs